Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.17
Delayed Data
As of May 26
 +0.08 / +0.66%
Today’s Change
8.67
Today|||52-Week Range
14.55
+13.74%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.09
Today’s open12.20
Day’s range12.07 - 12.59
Volume1,283,228
Average volume (3 months)1,276,082
Market cap$1.3B
Dividend yield8.22%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio19.0
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.40+1.03%
EBSEmergent BioSolution...+1.91+6.32%
CORTCorcept Therapeutics...+0.63+5.40%
ARRYArray Biopharma Inc-0.11-1.33%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts